WHO ICTRP trial
A study on the immune response and safety of an RSV vaccine when given to adults…
JPRN-jRCT2031230191 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-jRCT2031230191 |
|---|---|
| Public title | A study on the immune response and safety of an RSV vaccine when given to adults 18 years of age and above who received lung or kidney transplant and are at an increased risk of respiratory syncytial virus lower respiratory tract disease and compared to healthy adults 50 years of age and above |
| Scientific title | A Phase 2b, randomized, controlled, open-label study to evaluate the immune response and safety of the RSVPreF3 OA investigational vaccine in adults (>-18 years of age) when administered to lung and renal transplant recipients comparing 1 versus 2 doses and compared to healthy controls (>-50 years… |
| Primary sponsor | Ogawa Masayuki |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Australia;Japan;Canada;Japan;Spain;Japan;Germany;Japan;Italy;Japan;Republic of Korea;Japan;United State;Japan |
| Conditions | Respiratory Syncytial Virus Infections |
| Interventions | The RSVPreF3 OA investigational vaccine will be administered intramuscularly as 1 dose to RSV_IC_1 and RSV_HA groups, and 2 doses to RSV_IC_2 group |
| Registration date | Jun 29, 2023 |
| Target size | 375 |
| Secondary IDs | Nil known |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: